Genomic characterization of a new endophyticStreptomyces kebangsaanensisidentifies biosynthetic pathway gene clusters for novel phenazine antibiotic production

PeerJ
2017.0

Abstract

<jats:sec><jats:title>Background</jats:title><jats:p><jats:italic>Streptomyces</jats:italic>are well known for their capability to produce many bioactive secondary metabolites with medical and industrial importance. Here we report a novel bioactive phenazine compound, 6-((2-hydroxy-4-methoxyphenoxy) carbonyl) phenazine-1-carboxylic acid (HCPCA) extracted from<jats:italic>Streptomyces kebangsaanensis</jats:italic>, an endophyte isolated from the ethnomedicinal<jats:italic>Portulaca oleracea.</jats:italic></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The HCPCA chemical structure was determined using nuclear magnetic resonance spectroscopy. We conducted whole genome sequencing for the identification of the gene cluster(s) believed to be responsible for phenazine biosynthesis in order to map its corresponding pathway, in addition to bioinformatics analysis to assess the potential of<jats:italic>S. kebangsaanensis</jats:italic>in producing other useful secondary metabolites.</jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The<jats:italic>S. kebangsaanensis</jats:italic>genome comprises an 8,328,719 bp linear chromosome with high GC content (71.35%) consisting of 12 rRNA operons, 81 tRNA, and 7,558 protein coding genes. We identified 24 gene clusters involved in polyketide, nonribosomal peptide, terpene, bacteriocin, and siderophore biosynthesis, as well as a gene cluster predicted to be responsible for phenazine biosynthesis.</jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>The HCPCA phenazine structure was hypothesized to derive from the combination of two biosynthetic pathways, phenazine-1,6-dicarboxylic acid and 4-methoxybenzene-1,2-diol, originated from the shikimic acid pathway. The identification of a biosynthesis pathway gene cluster for phenazine antibiotics might facilitate future genetic engineering design of new synthetic phenazine antibiotics. Additionally, these findings confirm the potential of<jats:italic>S. kebangsaanensis</jats:italic>for producing various antibiotics and secondary metabolites.</jats:sec>

Knowledge Graph

Similar Paper

Genomic characterization of a new endophytic<i>Streptomyces kebangsaanensis</i>identifies biosynthetic pathway gene clusters for novel phenazine antibiotic production
PeerJ 2017.0
Activation of a silent phenazine biosynthetic gene cluster reveals a novel natural product and a new resistance mechanism against phenazines
MedChemComm 2012.0
Identification of novel endophenaside antibiotics produced by Kitasatospora sp. MBT66
The Journal of Antibiotics 2015.0
Biosynthetic Capacities of Actinomysetes. No.27. Endophenazines A-D, New Phenazine Antibiotics from the Athropod Associated Endosymbiont Streptomyces anulatus. II. Structure Elucidation.
The Journal of Antibiotics 2002.0
Biosynthetic Capacities of Actinomysetes. No.27. Endophenazines A-D, New Phenazine Antibiotics from the Athropod Associated Endosymbiont Streptomyces anulatus. II. Structure Elucidation.
The Journal of Antibiotics 2002.0
Mutational analysis of a phenazine biosynthetic gene cluster in <i>Streptomyces anulatus</i> 9663
Beilstein Journal of Organic Chemistry 2012.0
Mutational analysis of a phenazine biosynthetic gene cluster in <i>Streptomyces anulatus</i> 9663
Beilstein Journal of Organic Chemistry 2012.0
Biosynthetic Capacities of Actinomysetes. No.26. Endophenazines A-D, New Phenazine Antibiotics from the Arthropod Associated Endosymbiont Streptomyces anulatus. I. Taxonomy, Fermentation, Isolation and Biological Activities.
The Journal of Antibiotics 2002.0
Biosynthetic Capacities of Actinomysetes. No.26. Endophenazines A-D, New Phenazine Antibiotics from the Arthropod Associated Endosymbiont Streptomyces anulatus. I. Taxonomy, Fermentation, Isolation and Biological Activities.
The Journal of Antibiotics 2002.0
Bioactive phenazines from an earwig-associated Streptomyces sp.
Chinese Journal of Natural Medicines 2019.0